Unapproved New Drugs/Misbranded
Similar Posts
Fiscal Year 2025 Generic Drug Science and Research Initiatives Public Workshop – 06/03/2025
Fiscal Year 2025 Generic Drug Science and Research Initiatives Public WorkshopCDER Guidance Agenda
CDER Guidance AgendaCompleted BsUFA III Deliverables
Since the passage of the Biosimilar User Fee Act (BsUFA) in 2012, user fees have played an important role in expediting the process for the review of biosimilar products.MKS Enterprise, LLC – 624478 – 07/01/2022
Interstate Commerce/Food/AdulteratedField Science – Laboratory Manual
The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and courOwen Biosciences, Inc. – 710275 – 10/30/2025
CGMP/Finished Pharmaceuticals/Adulterated
